€114.35
1.76% yesterday
L&S, Jun 28, 10:55 pm CET
ISIN
NL0012044747
Symbol
SAE
Index

Redcare Pharmacy Target price 2024 - Analyst rating & recommendation

Redcare Pharmacy Classifications & Recommendation:

Buy
67%
Hold
25%
Sell
8%

Redcare Pharmacy Target price

Target price €151.75
Course €114.00
Price potential
Number of estimates 12
12 Analysts have issued a price target Redcare Pharmacy 2025 . The average Redcare Pharmacy target price is €151.75. This is higher than the current share price. The highest price target is
€190.00 66.67%
register free of charge
, the lowest is .
A rating was issued by 12 analysts: 8 Analysts recommend Redcare Pharmacy to buy, 3 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst estimates: Analysts believe that the Redcare Pharmacy share has an average upside potential 2025 of . Most analysts recommend the Redcare Pharmacy share at Purchase.

Sales and margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Turnover Billion € 1.80 2.38
49.36% 32.37%
EBITDA margin 2.25% 2.98%
276.87% 32.19%
Net margin -0.70% -0.32%
90.24% 54.36%

11 Analysts have issued a sales forecast Redcare Pharmacy 2024 . The average Redcare Pharmacy sales estimate is

€2.4b
unlock
. This is
19.83% higher
unlock
than the turnover of the last 12 months(TTM). The highest sales forecast is
€2.4b 22.13%
unlock
, the lowest is
€2.3b 15.89%
unlock
.

This results in the following potential growth figures:

Sales forecast

2023 €1.8b 49.36%
2024
€2.4b 32.37%
unlock
2025
€2.9b 21.76%
unlock
2026
€3.5b 19.43%
unlock
2027
€4.0b 16.05%
unlock
2028
€4.6b 14.66%
unlock

11 Analysts have issued an Redcare Pharmacy EBITDA forecast 2024. The average Redcare Pharmacy EBITDA estimate is

€71.0m
unlock
. This is
24.84% lower
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€84.0m 11.02%
unlock
, the lowest is
€57.8m 38.77%
unlock
.

This results in the following potential growth figures and future EBITDA margins:

EBITDA forecast

2023 €40.6m 364.17%
2024
€71.0m 74.98%
unlock
2025
€120m 68.77%
unlock
2026
€173m 44.26%
unlock
2027
€277m 60.06%
unlock
2028
€319m 15.46%
unlock

EBITDA margin

2023 2.25% 276.87%
2024
2.98% 32.19%
unlock
2025
4.13% 38.59%
unlock
2026
4.99% 20.82%
unlock
2027
6.88% 37.88%
unlock
2028
6.93% 0.73%
unlock

9 Redcare Pharmacy Analysts have issued a net profit forecast 2024. The average Redcare Pharmacy net profit estimate is

€-7.5m
unlock
. This is
24.88% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€7.4m 174.03%
unlock
, the lowest is
€-21.6m 115.98%
unlock
.

This results in the following potential growth figures and future net margins:

Net profit forecast

2023 €-12.6m 85.42%
2024
€-7.5m 40.38%
unlock
2025
€26.2m 448.40%
unlock
2026
€61.0m 132.79%
unlock
2027
€133m 118.28%
unlock
2028
€196m 47.37%
unlock

Net margin

2023 -0.70% 90.24%
2024
-0.32% 54.36%
unlock
2025
0.90% 381.25%
unlock
2026
1.76% 95.56%
unlock
2027
3.31% 88.07%
unlock
2028
4.26% 28.70%
unlock

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Earnings per share -0.63 -0.38
85.42% 39.68%
P/E ratio negative
EV/Sales 0.98

9 Analysts have issued a Redcare Pharmacy forecast for earnings per share. The average Redcare Pharmacy <a href=/blog/eps>EPS is

€-0.38
unlock
. This is
24.00% higher
unlock
than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is
€0.37 174.00%
unlock
, the lowest is
€-1.08 116.00%
unlock
.

This results in the following potential growth figures and future valuations:

Earnings per share

2023 €-0.63 85.42%
2024
€-0.38 39.68%
unlock
2025
€1.31 444.74%
unlock
2026
€3.05 132.82%
unlock
2027
€6.65 118.03%
unlock
2028
€9.80 47.37%
unlock

P/E ratio

Current -228.69 685.61%
2024
-303.61 32.76%
unlock
2025
87.10 128.69%
unlock
2026
37.42 57.04%
unlock
2027
17.14 54.20%
unlock
2028
11.63 32.15%
unlock

Based on analysts' sales estimates for 2024, the Redcare Pharmacy share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of

and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of .

This results in the following potential growth figures and future valuations:

EV/Sales

Current 1.18 24.84%
2024
0.98 16.86%
unlock
2025
0.81 17.87%
unlock
2026
0.67 16.27%
unlock
2027
0.58 13.83%
unlock
2028
0.51 12.80%
unlock

P/S ratio

Current 1.15 20.41%
2024
0.96 16.55%
unlock
2025
0.79 17.88%
unlock
2026
0.66 16.27%
unlock
2027
0.57 13.83%
unlock
2028
0.50 12.78%
unlock

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now